Guaifenesin 11673-0539-02
- Manufacturer
- Target Corporation
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- August 1, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA213420
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Selected Package
11673-0539-02Selected20 TABLET in 1 BLISTER PACK (11673-539-02)